Logiscreen

TherapeuticsMD Inc

$1.99
Market Cap 23.03M
ROE 0.7%
Gross Margin 100.0%
Debt/Equity 0.2
Current Ratio 3.1
Revenue QoQ 84.2%
EPS QoQ -1.2%
F-Score 5

About

TherapeuticsMD was previously a women’s healthcare company with a mission of creating and commercializing innovative products to support the lifespan of women from pregnancy prevention through menopause. In December 2022, the Company changed its business to become a pharmaceutical royalty company, primarily collecting royalties from its licensees. The Company is no longer engaging in research and development or commercial operations.

Exchange
NASDAQ
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Sector context

Healthcare

Overvalued

Trading at a discount to sector peers

P/E
129.32
vs median 33.61
P/B
0.86
vs median 2.16
ROE
0.01
vs median 0.09

Decent quality with acceptable fundamentals

Small-cap company with higher volatility

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics